Chemocentryx Stock Valuation

CCXI -  USA Stock  

USD 15.32  0.21  1.39%

Do you want to know what the current value of Chemocentryx is today? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Chemocentryx, is its stock price multiplied by the total number of shares outstanding, calculating Chemocentryx's enterprise value requires a different approach. It uses Chemocentryx's balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Chemocentryx Enterprise Value is most likely to increase significantly in the upcoming years. The preceding year's Enterprise Value was reported at 4.29 Billion. The current Tangible Asset Value is estimated to increase to about 559.9 M, while Free Cash Flow is projected to decrease to (99.1 M).
Chemocentryx shows a prevailing Real Value of $17.92 per share. The current price of the firm is $15.32. At this time, the firm appears to be undervalued. Our model approximates the value of Chemocentryx from analyzing the firm fundamentals such as return on equity of (30.10) %, and Profit Margin of (91.54) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will blend.

Search Valuation 

Chemocentryx Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Chemocentryx's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
4th of August 2021
Please note that Chemocentryx's price fluctuation is unstable at this time. Calculation of the real value of Chemocentryx is based on 3 months time horizon. Increasing Chemocentryx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chemocentryx is useful when determining the fair value of the Chemocentryx stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chemocentryx. Since Chemocentryx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemocentryx Stock. However, Chemocentryx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Chemocentryx helps investors to forecast how Chemocentryx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemocentryx more accurately as focusing exclusively on Chemocentryx's fundamentals will not take into account other important factors:
Estimates (6)
LowProjected EPSHigh
LowEstimated ValueHigh
LowNext ValueHigh
6 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. Some money managers use Chemocentryx's intrinsic value based on its ongoing forecasts of Chemocentryx's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by look to relative valuation against Chemocentryx's closest peers. When choosing a valuation method Chemocentryx, make sure it is appropriate for the firm given its current financial situation and market classification. If more than one is valuation category is appropriate, we suggest using both methods to arrive at a better estimate.

Chemocentryx Investments

461.87 MillionShare

Chemocentryx Valuation Drivers Correlation

Many accounts on the financial statements of Chemocentryx are highly interrelated and sometimes correlated. Consequently, when conducting Chemocentryx's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Chemocentryx
Click cells to compare fundamentals

Chemocentryx Market Cap

Chemocentryx is number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is currently estimated at about 2.23 Billion. Chemocentryx totals roughly 1.03 Billion in market capitalization claiming about 46% of stocks in Biotechnology industry.
Capitalization  Total debt  Revenue  Valuation  Workforce

Chemocentryx Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Chemocentryx's current stock value. Our valuation model uses many indicators to compare Chemocentryx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chemocentryx competition to find correlations between indicators driving Chemocentryx's intrinsic value. More Info.
Chemocentryx is number one stock in price to book category among related companies. It is number one stock in price to earning category among related companies reporting about  14.17  of Price to Earning per Price to Book. . The current Price to Earnings Ratio is estimated to decrease to -75.65. The current Earnings Before Interest Taxes and Depreciation Amortization EBITDA is estimated to decrease to about (51.3 M)

About Chemocentryx Valuation

The equity valuation mechanism determines the current worth of Chemocentryx on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Chemocentryx. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Chemocentryx based exclusively on its fundamental and basic technical indicators. By analyzing Chemocentryx's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Chemocentryx's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Chemocentryx. We calculate exposure to Chemocentryx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Chemocentryx's related companies.
Last ReportedProjected for 2021
Gross Profit64.9 M54.5 M
Profit Margin(0.85) (0.92) 
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in Mountain View, California. Chemocentryx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 133 people.

Chemocentryx Quarterly Enterprise Value

3.6 BillionShare

Chemocentryx Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Chemocentryx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio7.06
Revenue Growth72.30%
Enterprise Value To Ebitda-9.62
Enterprise Value To Revenue8.56

Chemocentryx Current Valuation Indicators

Valuation refers to the process of determining the present value of Chemocentryx and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Chemocentryx we look at many different elements of the entity such as Chemocentryx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Continue to Trending Equities. Note that the Chemocentryx information on this page should be used as a complementary analysis to other Chemocentryx's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Chemocentryx Stock analysis

When running Chemocentryx price analysis, check to measure Chemocentryx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemocentryx is operating at the current time. Most of Chemocentryx's value examination focuses on studying past and present price action to predict the probability of Chemocentryx's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Chemocentryx's price. Additionally, you may evaluate how the addition of Chemocentryx to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
The market value of Chemocentryx is measured differently than its book value, which is the value of Chemocentryx that is recorded on the company's balance sheet. Investors also form their own opinion of Chemocentryx's value that differs from its market value or its book value, called intrinsic value, which is Chemocentryx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemocentryx's market value can be influenced by many factors that don't directly affect Chemocentryx underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemocentryx's value and its price as these two are different measures arrived at by different means. Investors typically determine Chemocentryx value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemocentryx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.